Neonatal Sepsis Caused by Human Parechovirus Type A3 With Marked Hyperferritinemia: A Case Report. [PDF]
Ochi F +6 more
europepmc +1 more source
Wet Nursing and Human Milk Sharing: Reviving Sustainable Systems to Prioritise Breastfeeding
ABSTRACT The 2025 call of the World Alliance for Breastfeeding Action (WABA) is to prioritise breastfeeding through creating sustainable support systems. This is based on the strong foundations of breastfeeding and the unique properties of human milk to nourish, protect and provide optimal physical, emotional and cognitive growth for the infant ...
Anna Coutsoudis +3 more
wiley +1 more source
Risk prediction of healthcare-associated neonatal sepsis in Amhara, Ethiopia: A prospective cohort study. [PDF]
Najjar N +15 more
europepmc +1 more source
Mortality Patterns and Phenotypic Clusters in Trisomy 13: A Population‐Based Study From Japan
ABSTRACT Trisomy 13, the third most common autosomal trisomy after trisomy 21 and trisomy 18, is associated with a significantly high infant mortality rate. However, large‐scale studies examining causes of death in trisomy 13 remain scarce. Therefore, we aimed to better understand the mortality patterns.
Narumi Kato +2 more
wiley +1 more source
Clinical, laboratory, and microbiological differences between early- and late-onset neonatal sepsis in preterm infants: a cross-sectional study in Vietnam. [PDF]
Mai Trong H +7 more
europepmc +1 more source
ABSTRACT O‐GlcNAc transferase (OGT) and its antagonist O‐GlcNAcase (OGA) regulate protein O‐GlcNAcylation, a highly conserved post‐translational modification involved in metabolic sensing. Pathogenic variants in the OGT gene cause an X‐linked congenital disorder of glycosylation (OGT‐CDG) presenting developmental delay, hypotonia, intellectual ...
Alfonso Manuel D'Alessio +12 more
wiley +1 more source
Global, regional, and national incidence and mortality of neonatal sepsis and other neonatal infections, 1990-2021 and predictions to 2050. [PDF]
Jiang K +7 more
europepmc +1 more source
Pharmacokinetics of teicoplanin in paediatric patients—A systematic review of current literature
Background and Objective Teicoplanin is commonly used in children to treat gram‐positive infections and is sometimes used off‐label prophylactically in surgical or paediatric oncology settings. The pharmacokinetics (PK) of teicoplanin in children exhibit considerable variability, such as in critically ill children or those with renal impairment.
Noa E. Wijnen +4 more
wiley +1 more source
Beyond the samples: Nigerian research staff perspectives on a multicentre neonatal sepsis study's impact. [PDF]
Akpulu C +20 more
europepmc +1 more source

